SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 64 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $39,495 | -10.2% | 36,911 | +29.4% | 0.00% | 0.0% |
Q3 2022 | $44,000 | -22.8% | 28,515 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $57,000 | +5.6% | 28,515 | +23.5% | 0.00% | 0.0% |
Q1 2022 | $54,000 | -49.5% | 23,089 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $107,000 | -33.1% | 23,089 | +10.1% | 0.00% | -33.3% |
Q3 2021 | $160,000 | -21.2% | 20,966 | 0.0% | 0.01% | -14.3% |
Q2 2021 | $203,000 | +17.3% | 20,966 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $173,000 | +21.0% | 20,966 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $143,000 | -31.9% | 20,966 | +11.2% | 0.01% | -30.0% |
Q3 2020 | $210,000 | +116.5% | 18,862 | +21.8% | 0.01% | +100.0% |
Q2 2020 | $97,000 | +470.6% | 15,491 | +63.5% | 0.01% | +400.0% |
Q1 2020 | $17,000 | -46.9% | 9,475 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $32,000 | +60.0% | 9,475 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $20,000 | -20.0% | 9,475 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $25,000 | -26.5% | 9,475 | +30.8% | 0.00% | -50.0% |
Q1 2019 | $34,000 | +100.0% | 7,245 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $17,000 | -46.9% | 7,245 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $32,000 | -38.5% | 7,245 | 0.0% | 0.00% | -66.7% |
Q2 2018 | $52,000 | +477.8% | 7,245 | +231.0% | 0.00% | – |
Q1 2017 | $9,000 | – | 2,189 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
TRUST CO OF VERMONT | 204 | $19 | 0.00% |
SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |